Cite

HARVARD Citation

    Faivre-Finn, C. et al. (2021). Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC). Lung cancer. pp. 30-38. [Online]. 
  
Back to record